Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.

Y. Miao; D. Dobre; H.J. Lambers Heerspink; B.M. Brenner; M.E. Cooper; H. H. Parving; S. Shahinfar; D.E. Grobbee; D. de Zeeuw

Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.

Y. Miao
, D. Dobre
, H.J. Lambers Heerspink
, B.M. Brenner
, M.E. Cooper
, H. H. Parving
, S. Shahinfar
, D.E. Grobbee
, D. de Zeeuw

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	44-50
Number of pages	7
Journal	Diabetologia
Volume	54
Issue number	1
Publication status	Published - 2011

Cite this

@article{57b4e7f642d3484e9a7f3ed4f133c061,

title = "Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.",

author = "Y. Miao and D. Dobre and \{Lambers Heerspink\}, H.J. and B.M. Brenner and M.E. Cooper and Parving, \{H. H.\} and S. Shahinfar and D.E. Grobbee and \{de Zeeuw\}, D.",

year = "2011",

language = "English",

volume = "54",

pages = "44--50",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Increased serum potassium affects renal outcomes: a post hoc analysis of the reduction of endpoints in NIDOM with the Angiotensin II Antagonist Losartan (Renaal) trial.

AU - Miao, Y.

AU - Dobre, D.

AU - Lambers Heerspink, H.J.

AU - Brenner, B.M.

AU - Cooper, M.E.

AU - Parving, H. H.

AU - Shahinfar, S.

AU - Grobbee, D.E.

AU - de Zeeuw, D.

PY - 2011

Y1 - 2011

M3 - Article

SN - 0012-186X

VL - 54

SP - 44

EP - 50

JO - Diabetologia

JF - Diabetologia

IS - 1

ER -